Regencell Bioscience

RGC

Market cap $5.94B

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

New class action for Regencell (RGC) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/23/2026

NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Regencell Bioscience Holdings Limited (NASDAQ: RGC).

VANCOUVER, BC / ACCESS Newswire / June 18, 2026 / Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) (the "Company" or "Relevant Gold") is pleased to announce the voting results from its Annual and Special General Meeting of Shareholders (the "Meeting") held today in Vancouver, British Columbia. Shareholders approved all matters brought before the Meeting, including: Setting the number of directors at six; The election of all director nominees; The appointment of Smythe LLP as auditor of the Company for the ensuing year and authorized the directors to fix the auditor's remuneration; and Re-approval of the Company's Omnibus Equity Incentive Compensation Plan.

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

Alert: Claims Focus on Alleged Misrepresentations About Regencell's $1 Million R&D Budget Versus $14 Billion Market Valuation NEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities of a pending securities class action. THE CASE: A class action was filed, seeking to recover damages for investors who purchased Regencell securities between October 28, 2024 and October 31, 2025.

NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC) and certain officers. The class action, filed in the United States District Court for the District of Maryland, and docketed under 26-cv-01602, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Regencell securities between October 28, 2024 and October 31, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Airborne VTEM and magnetics survey identifies 44+ EM anomalies, including 15 high-priority targets, several coincident with known gold-bearing structures, surface geochemistry and 2024 drilling VANCOUVER, BC / ACCESS Newswire / June 18, 2026 / Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) (the "Company" or "Relevant Gold") is pleased to announce results from a 2,807 line-km Versatile Time Domain Electromagnetic ("VTEM") and magnetics survey completed across its 100%-owned South Pass Gold Camp in Wyoming, USA. The survey identified 44 EM anomalies, including 15 high-priority targets, and outlined structural corridors at Lewiston that are traceable for more than 3 kilometres ("km") along strike and to more than 400 metres ("m") depth.

NEW YORK, June 17, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the "Class Period"), of the important June 23, 2026 lead plaintiff deadline. So what: If you purchased Regencell securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Regencell (RGC) To Contact Him Directly To Discuss Their Options